Unexpectedly, most PBC patients had decreased γ-GT and Alk-p levels, which is a marker of UDCA response (21), after 1 year of UDCA treatment, regardless of baseline cirrhosis and UDCA response. This evidence concerns the gene ALK and Cirrhosis.